No Picture
PR Newswire

Aeonian Pharmaceuticals closes Seed Funding from Apollo Ventures to develop mTORC1 inhibitors

SAN FRANCISCO, Dec 11, 2017 /PRNewswire/ — Aeonian Pharmaceuticals, Inc. (“Aeonian”), a San Francisco Bay Area-based biopharmaceutical company, announced today the closing of a seed financing round. The financing was led by Apollo Ventures, a Life … […]

No Picture
News

Alzheimer’s grant

Three physician-scientists, including a top San Diego-based Alzheimer’s researcher, will get up to $70 million to accelerate clinical trials to find new treatments, under a grant from the National Institutes of Health. Dr. Paul Aisen, of the Univer… […]